What Researchers Did
Researchers conducted an updated systematic review and meta-analysis of seven randomized and pseudo-randomized studies to evaluate hyperbaric oxygen therapy (HBOT) for idiopathic sudden sensorineural hearing loss (ISSHL).
What They Found
Pooled analysis from five studies indicated that the chance of improvement following HBOT combined with steroids was greater than with steroids alone (RR 1.6, 95% CI 1.3 to 2...). However, data pooling was challenging due to variations in how pure tone average changes were reported across studies.
What This Means for Canadian Patients
For Canadian patients experiencing ISSHL, these findings suggest that adding hyperbaric oxygen therapy to standard steroid treatment could potentially improve hearing outcomes. This information may help inform treatment discussions and clinical guidelines for managing this condition.
Canadian Relevance
This study does not have a direct Canadian connection as none of the authors or institutions are identified as Canadian, nor does it specifically address Canadian healthcare contexts.
Study Limitations
A significant limitation was the difficulty in pooling data due to inconsistent reporting of pure tone average changes across the included studies.